Gayatri Bioorganics Reports Q1 FY2025-26 Results, Schedules 34th AGM

Gayatri Bioorganics Limited (GBL) has announced its unaudited financial results for the first quarter of the fiscal year 2025-26, along with other significant corporate updates. The company's board of directors convened on July 29, 2025, to review and approve these developments.

Financial Results

The board approved the unaudited financial results for the quarter ended June 30, 2025, which were reviewed by the audit committee. While specific financial figures were not disclosed in the announcement, the company stated that the results were prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013.

Annual General Meeting

Gayatri Bioorganics has scheduled its 34th Annual General Meeting (AGM) for August 26, 2025. In line with ongoing digital trends, the AGM will be conducted via video conference or other audio-visual means (OAVM), allowing shareholders to participate remotely.

Directors' Report

The board also approved the 34th Directors' Report for the financial year 2024-25. This report, along with the notice for convening the 34th AGM, will provide shareholders with a comprehensive overview of the company's performance and future outlook.

Business Continuity

It's worth noting that the financial statements were prepared on a going concern basis. The company has received a comfort letter from its promoters, indicating their support for the continuation of business operations in the future. This assurance is crucial for stakeholders and reflects the promoters' confidence in the company's prospects.

Operational Focus

Gayatri Bioorganics Limited continues to operate as a single-segment business. The company has not disclosed any plans for diversification or expansion into new segments at this time.

Regulatory Compliance

The financial results and other corporate actions announced are in compliance with Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This adherence to regulatory standards underscores GBL's commitment to transparency and good corporate governance.

As Gayatri Bioorganics Limited moves forward, stakeholders will be keenly watching the upcoming AGM for more detailed insights into the company's performance and strategic direction for the remainder of the fiscal year 2025-26.